Artificial Intelligence-Based Assessment of Endosseous Lesions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Bari Aldo Moro

About this trial

Despite these advances, CBCT interpretation remains largely qualitative and dependent on the clinician's experience. Conventional evaluation is based on two-dimensional slices and linear measurements, which may underestimate lesion complexity and spatial distribution.

Recent developments in Artificial Intelligence in Medicine have introduced automated image segmentation tools capable of identifying lesion boundaries and calculating volumetric data. These technologies allow a transition from subjective assessment to objective, reproducible quantification.

The potential clinical advantages include:

* Objective measurement of lesion size (volume in mm³) * Improved surgical planning * Enhanced prediction of anatomical involvement * Reduction of diagnostic errors * Standardization of follow-up and outcome assessment Therefore, the aim of the present study was to evaluate the clinical impact of AI-based segmentation and volumetric analysis of endosseous lesions compared to conventional CBCT interpretation.

Eligibility criteria

Qualifiers

Good health according to the System of the American Society of Anesthesiology

Aged older than 18 years

No general medical contraindication for surgery

Disqualifiers

Smoking more than 15 cigarettes a day

Pregnancy

Acute infections

Trial design

Treatments tested in this trial

  • AI assisted Evaluation

Treatment groups

10 Participants
are divided into 2 treatment groups

Sponsors and collaborators